Exchange: NASDAQ·Updated 07:30 PM EST
XENE logo

XENE Xenon Pharmaceuticals Inc

$39.05
$1.22
(3.01%)
Today
Closed $39.26
$0.21
(0.54%)
After Hours
Reported EarningsNov 9
Mkt Cap$3.98B
Vol1.1M

About XENE

Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
49

Neutral Sentiment

How do you feel about XENE?

usedgum
$XENE what does the day holds. She likes it. Let’s see if she was right about that dip a while back.
1
shoc24
$XENE reported earnings after the close today. GAAP EPS beat estimates: -$1.11 vs. -$1.13 expected, according to Stock Meadow.
shoc24
$XENE reports earnings today after the close. I used Stock Meadow's earnings dashboard to review its history: XENE has beaten EPS estimates in 5 of its last 8 reports.
Laei
$XENE Co-founder Simon Pimstone stepped down as CEO in 2021 and left the board in 2024. Form 4s show he exercised options and sold shares around $38-40 in 2023. It puzzles me that he sold shares and left if he truly believes in the science he built. Does anyone know if he still holds a meaningful stake, or why he left? Not advice, just curious.

Advertisement|Remove ads.